ConductScience.org, home

Paper7138762

The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process.

Weichselbaum RR and 1 other. Br J Cancer, 1982. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process. Papers, record 7138762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7138762

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process.
PubMed
Journal
Br J Cancer
PubMed
Year
1982
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
2.14
iCite
Revised in PubMed
2019-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weichselbaum RRR R
2Little JBJ B

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Cell SurvivalMajor topic
MelanomaMajor topic
Cell Line
Dose-Response Relationship, Radiation
Female
Humans
Neoplasms, Experimental
Time Factors

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1277716Evolution in vitro of stemlines with minimal karyotypic deviations in a human heteroploid cell line.J Natl Cancer Inst1978https://conductscience.org/library/papers/277716PubMed
24810908Repair of potentially lethal damage in vivo in solid tumor cells after x-irradiation.Cancer Res1974https://conductscience.org/library/papers/4810908PubMed
313819951X-ray damage and recovery in mammalian cells in culture.Nature1959https://conductscience.org/library/papers/13819951PubMed
41000466Radiation therapy of malignant melanoma: experience with high individual treatment doses.Cancer1976https://conductscience.org/library/papers/1000466PubMed
5202386In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice.Cancer Res1978https://conductscience.org/library/papers/202386PubMed
67059452Cellular repair factors influencing radiocurability of human malignant tumours.Br J Cancer1982https://conductscience.org/library/papers/7059452PubMed
754693Hypoxic cell sensitisers in radiotherapy.Lancet1976https://conductscience.org/library/papers/54693PubMed
84216482On the relative importance of hypoxic cells for the radiotherapy of human tumours.Eur J Cancer (1965)1974https://conductscience.org/library/papers/4216482PubMed
95361657Repair of sub-lethal and potentially lethal radiation damage in plateau phase cultures of human cells.Nature1969https://conductscience.org/library/papers/5361657PubMed
10935443Visual complications following irradiation for pituitary adenomas and craniopharyngiomas.Radiology1976https://conductscience.org/library/papers/935443PubMed
114719049Fractionated radiation response of human cells in stationary and exponential phases of growth.Radiology1973https://conductscience.org/library/papers/4719049PubMed
124357757A human cell line from a pleural effusion derived from a breast carcinoma.J Natl Cancer Inst1973https://conductscience.org/library/papers/4357757PubMed
136930370X-ray sensitivity of human tumor cells in vitro.Int J Radiat Oncol Biol Phys1980https://conductscience.org/library/papers/6930370PubMed
147000122Analysis of tumour responses by excision and in vitro assay of cellular clonogenic capacity.Br J Cancer Suppl1980https://conductscience.org/library/papers/7000122PubMed
154684814Repair of potentially lethal radiation damage in vitro and in vivo.Radiology1973https://conductscience.org/library/papers/4684814PubMed
1677475Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.N Engl J Med1978https://conductscience.org/library/papers/77475PubMed
174713180A comparison of the effects of radiation on tumour growth delay and cell survival. The effect of oxygen.Br J Radiol1973https://conductscience.org/library/papers/4713180PubMed
184916152Radiobiology's contribution to radiotherapy: promise or mirage? Failla Memoral Lecture.Radiat Res1970https://conductscience.org/library/papers/4916152PubMed
201120301Repair of radiation damage in Lewis lung carcinoma cells following in situ treatment with fast neutrons and gamma-rays.Cancer Res1975https://conductscience.org/library/papers/1120301PubMed
21528265Timing of assays: an important consideration in the determination of clonogenic cell survival both in vitro and in vivo.Int J Radiat Oncol Biol Phys1979https://conductscience.org/library/papers/528265PubMed

See all 21 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
33187214The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment.Cancers (Basel)2020https://conductscience.org/library/papers/33187214PubMed
23370117Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.Mol Aspects Med2013https://conductscience.org/library/papers/23370117PubMed
16001975The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism.BMC Cancer2005https://conductscience.org/library/papers/16001975PubMed
10933048Induction and characterization of human glioma clones with different radiosensitivities.Neoplasia1999https://conductscience.org/library/papers/10933048PubMed
6320853The influence of inhibitors of poly (ADP-ribose) polymerase on X-ray-induced potentially lethal damage repair.Br J Cancer Suppl1984https://conductscience.org/library/papers/6320853PubMed
2503478Increased tumor control rates in murine fibrosarcoma by combined therapy with L-alanosine and radiation.Jpn J Cancer Res1989https://conductscience.org/library/papers/2503478PubMed
2390479The effect of L-dopa on the potentiation of radiation damage to human melanoma cells.Br J Cancer1990https://conductscience.org/library/papers/2390479PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7138762

GET https://conductscience.org/api/papers/v1/7138762/references?page=2